The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.
The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.
Only two weeks left to participate in The Scientist’s 2013 survey for best place to work in the life sciences.
A third dose of the MMR vaccine given during an intense outbreak appears to have provided herd-immunity to control the spread of the disease.
Successive awakening of soil microbes drives a huge pulse of CO2 following the first rain after a dry summer.
Quantitative real-time technology dominates the market today but digital PCR is on the rise.
Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.
Check out the breakdown of this year's Salary Survey data, including how compensation differs between sex, sector, and state.
Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.
Individuals of a newly discovered microbe species line up end-to-end to form electron transport cables many times their length.
The federal government tightens regulations on SARS and other deadly viruses, but the changes could hamper research.